Objective: To test the hypothesis that once-daily treatment with fluticasone ... receiving fluticasone propionate 50µg twice daily via a Diskus™ inhalation device. Patients whose asthma was ...

Treatment for two weeks with either oral prednisolone (30 mg/day), high dose fluticasone propionate (2000 μg/day, FP2000), or lower dose FP (500 μg/day, FP500), both given by a dry powder inhaler, ...

This was a randomised, double-blind, parallel-group study that was conducted in 86 UK primary-care centres. Patients attended the clinic on five occasions: before and after the 4-week run-in ...

Inhalation lung delivery presents a promising alternative ... This customization capability aligns with the need for personalized treatment approaches, enhancing device versatility and clinical ...

Dry powder inhalers (DPIs) have about 20-fold lower carbon footprint (CO ... CO 2 FP analysis and LCA of four different Easyhaler® (EH) products available for the treatment of asthma and COPD ...

Major companies in the dry powder inhaler market are focusing on innovation, developing products with muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD), and ...

Teva will make two inhaler products available through this program: generic versions of the AirDuo®RespiClick® (fluticasone propionate/salmeterol xinafoate maintenance inhaler) and ProAir® HFA ...

Teva will make two inhaler products available through this program: generic versions of the AirDuo®RespiClick® (fluticasone propionate/salmeterol xinafoate maintenance inhaler) and ProAir® HFA ...

I remember him using an inhaler. A quick search online ... I get a whiff of its magical powder, fluticasone propionate and salmeterol. The first is a steroid that reduces swelling in the airways.

Inhalation Powder is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus. Limitations of Use: Not recommended for the treatment of diabetic ...